Literature DB >> 8658638

Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.

Y Kita1, Y Iwaki, K Noguchi, B P Griffith, A G Tzakis, S Todo, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8658638      PMCID： PMC2955296     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Evaluation of sequential serum interleukin-6 levels in liver allograft recipients.

Authors:  Y Kita; Y Iwaki; A J Demetris; T E Starzl
Journal:  Transplantation       Date:  1994-04-15       Impact factor: 4.939

2.  Production of cytokines (TNF-alpha, IL-1-beta) and endothelial cell activation in human liver allograft rejection.

Authors:  M W Hoffmann; K Wonigeit; G Steinhoff; H Herzbeck; H D Flad; R Pichlmayr
Journal:  Transplantation       Date:  1993-02       Impact factor: 4.939

3.  Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro.

Authors:  K Matsumoto; H Fujii; G Michalopoulos; J J Fung; A J Demetris
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

4.  Sequential determinations of serum interleukin 6 levels as an immunodiagnostic tool to differentiate rejection from nephrotoxicity in renal allograft recipients.

Authors:  N Yoshimura; T Oka; B D Kahan
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939
  4 in total
  1 in total

1.  Pediatric patients receiving ABO-incompatible living related liver transplantation exhibit higher serum transforming growth factor-β1, interferon-γ and interleukin-2 levels.

Authors:  Mohamed Hamed Hussein; Takashi Hashimoto; Ghada AbdEl-Hamid Daoud; Takazumi Kato; Masahito Hibi; Hirokazu Tomishige; Fujio Hara; Tatsuya Suzuki; Yoko Nakajima; Tatenobu Goto; Tetsuya Ito; Ineko Kato; Atsushi Sugioka; Hajime Togari
Journal:  Pediatr Surg Int       Date:  2011-03       Impact factor: 1.827
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.